Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Journal of Proteomics
- Vol. 113, 326-336
Abstract
No abstract availableKeywords
Funding Information
- Carolinas HealthCare System (CMC 08-026)
This publication has 28 references indexed in Scilit:
- The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell CarcinomasMolecular Cancer Therapeutics, 2014
- Comparative label‐free LC‐MS/MS analysis of colorectal adenocarcinoma and metastatic cells treated with 5‐fluorouracilProteomics, 2012
- 2-DE-Based Proteomics for the Analysis of Metastasis-Associated Proteins2012
- Identification of Key Players for Colorectal Cancer Metastasis by iTRAQ Quantitative Proteomics Profiling of Isogenic SW480 and SW620 Cell LinesJournal of Proteome Research, 2011
- ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomasOral Diseases, 2010
- Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics AnalysisJournal of Proteome Research, 2009
- Proteomics in Tumor Progression and MetastasisAnnals of the New York Academy of Sciences, 2005
- Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary glandOral Oncology, 2004
- Liver-Type Fatty Acid-Binding Protein Is Highly Expressed in Intestinal Metaplasia and in a Subset of Carcinomas of the Stomach without Association with the Fatty Acid Synthase Status in the CarcinomaPathobiology, 2004
- Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationProstaglandins, Leukotrienes and Essential Fatty Acids, 2003